The Q1 cohort demonstrated significantly elevated expression of CCNA2, CCNB1, CCND1, and CDH2, indicating CDC25A’s potential regulatory role in coordinating melanoma cell cycle progression with EMT dynamics. The gene discussed is CDH2; the disease is melanoma.